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ABSTRACT
Alternative translation initiation (ATI) is a mechanism
of producing multiple proteins from a single tran-
script, which in some cases regulates trafficking of
proteins to different cellular compartments, including
mitochondria. Application of a genome-wide compu-
tational screen predicts a cryptic mitochondrial
targeting signal for 126 proteins in mouse and man
that is revealed when an AUG codon located down-
stream from the canonical initiator methionine codon
is used as a translation start site, which we term
downstream ATI (dATI). Experimental evidence in
support of dATI is provided by immunoblotting of
endogenous truncated proteins enriched in mito-
chondrial cell fractions or of co-localization with
mitochondria using immunocytochemistry. More
detailed cellular localization studies establish
mitochondrial targeting of a member of the cytosolic
poly(A) binding protein family, PABPC5, and of the
RNA/DNA helicase PIF1a. The mitochondrial
isoform of PABPC5 co-immunoprecipitates with the
mitochondrial poly(A) polymerase, and is markedly
reduced in abundance when mitochondrial DNA
and RNA are depleted, suggesting it plays a role in
RNA metabolism in the organelle. Like PABPC5 and
PIF1a, most of the candidates identified by the
screen are not currently annotated as mitochondrial
proteins, and so dATI expands the human mitochon-
drial proteome.
INTRODUCTION
Products of nuclear genes dominate the mitochondrial
proteome. They are synthesized by cytosolic ribosomes
and imported into mitochondria via specific pathways
according to their final destination in the organelle (1).
The most extensively used system for importing
matrix-destined mitochondrial proteins depends on a posi-
tively charged amphipathic a helix, located at the amino
(N-) terminus of the protein, which functions as a mito-
chondrial targeting signal (MTS). Cytosolic proteins chap-
erone mitochondrial precursors to an import complex
located on the outer surface of the mitochondrion,
termed the translocase of the outer membrane (TOM)
complex. The MTS can interact with import receptors
and direct proteins across both the outer and inner mito-
chondrial membranes. Matrix-destined proteins depend
additionally on the translocase of the inner membrane
(TIM) complex, specifically TIM23, to direct them to
the innermost compartment of the organelle. The insertion
of proteins into the TIM23 channel requires a membrane
potential across the inner mitochondrial membrane, and a
further driving force is provided by the presequence
translocase-associated motor complex. Upon entry to
the matrix, many proteins have the MTS removed by
the mitochondrial processing peptidase, and chaperones
facilitate the proper folding of the mature protein into
its active conformation (1,2). Although many genes
encode dedicated mitochondrial proteins, an increasing
number are recognised to specify multiple protein
isoforms that are found in more than one cellular compart-
ment. Protein variants that are targeted to different cellular
compartments can be synthesized from a single gene, or
transcript, via the use of alternative splice sites, transcrip-
tion start sites or translation initiation sites (3). Alternative
translation initiation (ATI), first discovered in viruses
(4,5), and subsequently in eukaryotes (6), is a mechanism
by which more than one initiation codon within a single
mRNA results in the translation of proteins with distinct
N-termini (3,7). ATI diversifies the proteome andmay alter
a protein’s function or cellular location.
The use of an MTS lends itself to ATI, as essentially the
same mature protein can be made for two compartments
from one gene. RNase H1 is typical of this class of genes
(8). Other documented examples of ATI-dependent
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dual targeting include iron–sulfur cluster assembly enzyme
(NFS1) and insulin-degrading enzyme (9,10). Translation
initiation from the second, or a subsequent, AUG codon,
which we term downstream ATI (dATI), is a less obvious
method of achieving mitochondrial targeting, as the
mature mitochondrial protein necessarily lacks a portion
of the N-terminus that is present when initiation occurs
from the first AUG codon. The thyroid hormone receptor,
c-Erb A a1, was thought to be a rare case of mitochondrial
targeting via dATI (11).
Our studies of nucleic acid-transacting proteins in
mitochondria led us to the finding that dATI yields a
mitochondrial isoform of flap endonuclease 1, FEN1
(manuscript in preparation). Taken together with the
previous instance of dATI-mediated mitochondrial target-
ing of the thyroid hormone receptor, the possibility arose
that this might be a commonplace mechanism of mito-
chondrial targeting. Therefore, using a computational
approach, an inventory comprising 126 genes encoding
candidate dATI-dependent mitochondrial isoforms was
assembled. Experimental validation of a subset of the
putative genes from the list provided empirical evidence
of mitochondrial localization, indicating that mitochon-
drial targeting via dATI is much more widespread than
recognized hitherto.
MATERIALS AND METHODS
Cell culture and transfections
Human 143B osteosarcoma (HOS) cells were maintained
in DMEM supplemented with 0.1% penicillin/strepto-
mycin and 10% FBS. Flp-In
TM
T-REx
TM
293 (HEK293T)
cells (Invitrogen) were cultured in DMEM, 0.1%
penicillin/streptomycin, 10% tetracycline-free FBS,
15 mg/ml Blasticidin (InvivoGen) and 100 mg/ml Zeocin
(Invivogen). HEK293T cells were co-transfected, using
Lipofectamine 2000 (Invitrogen), with 1350 ng pOG44
plasmid (invitrogen) and 150 ng of cDNA ligated into
pcDNA5/FRT/TO (Invitrogen). Stable transfectants
were selected with 100mg/ml Hygromycin B (Invivogen).
Construct design and site-directed mutagenesis
Pif1, Pabpc5 and Pop1 cDNAs were ligated as KpnI-XhoI
fragments into the pcDNA5/FRT/TO MCS. Mutant con-
structs were made using the QuikChange site-directed
mutagenesis kit (Stratagene).
Confocal microscopy
HOS cells were grown on glass coverslips and transiently
transfected using Lipofectamine 2000 with 1.5 mg of Pif1,
Pabpc5 and Pop1 cDNAs. Twenty-four hours after
transfection, HOS cells were incubated with anti-HA
(1:200; Roche Diagnostics) or anti-FLAG (1:400; Sigma)
antibodies, followed by treatment with appropriate
fluorescently labelled secondary antibodies. Coverslips
were mounted with 1,4-diazabicyclo[2.2.2]octane
(Sigma), containing 4’,6-diamidino-2-phenylindole,
dihydrochloride (DAPI). Images were acquired with an
LSM 510 META confocal microscope (Carl Zeiss, Jena,
Germany).
Immunoblotting
Proteins were resolved by 4–12% NuPAGE Bis–Tris
SDS-PAGE (Invitrogen) and transferred to nitrocellulose
membrane (Whatman), which were incubated at 4C over-
night with primary antibodies. The concentrations of
primary antibodies from Abcam were as follows:
GAPDH (1:20 000), HSP60 (1:60 000), SF2 (1:3000),
BMS1L (1:200), B23 (1:1000), PABPC1 (1:1000),
FIBRILLARIN (1:2000), ARAP1 (1:500), MTSS1L
(1:1000), FBXL12 (1:2000), LEPRE1 (1:1000), PABPC5
(1:500), NOX3 (1:1000), TNIK (1:2000), MBRL (1:1000),
FOXH1, (1:1000), PRPSAP2 (1:1000), CLASP2 (1:2000),
GCN1L1 (1:2000), Histone H2A (1:1000), mtPAP
(1:1000), MRPS18 (1:1000), COXIV (1:1000), Aconitase
II (1:1000), CYT C (1:5000) and NRF1 (1:500). The con-
centrations of primary antibodies from Santa Cruz were
as follows: PIF1 (1:200), POLG1 (1:500), PCNA (1:400),
LRPPRC (1:2000), Utrophin (1:200), TOM20 (1:4000)
and SSBP1 (1:500). The concentrations of primary
antibodies from Sigma were as follows: FLAG (1:1000)
and Tubulin (1:2000). Other antibodies used were as
follows: NDUFB8 (1:1000; Invitrogen), HA (1:2000;
Roche), TWINKLE (1:200; A. Suomalainen), TFAM
(1:80 000; R. Wiesner) and TRIM32 (1:1000; D. Blake).
Secondary antibodies were anti-rabbit or anti-mouse HRP
(Promega). Membranes were visualized with enhanced
chemiluminescence (ECL) plus immunoblotting detection
system (GE Healthcare).
Mitochondrial import
[35S]-methionine-labelled proteins were generated with the
TNT Quick Coupled Transcription/Translation System
(Promega) according to the manufacturer’s instructions.
Labelled proteins were incubated with rat liver
mitochondria prepared by differential centrifugation and
import was assessed via trypsin protection and
FCCP-dependent inhibition (12). Import reactions were
carried out at 37C for 1 h and then subjected to
SDS-PAGE. Gels were dried, exposed to storage
phosphor screens (GE Healthcare), visualized on the
Typhoon 9410 Variable Mode Imager (Amersham
Biosciences) and quantified using ImageQuant 5.2.
Nuclear, cytosolic and mitochondrial isolation
from cultured cells
HEK293T cells were homogenized in hypotonic buffer
(20mM HEPES–NaOH [pH 7.8], 5mM KCl, 1.5mM
MgCl2, 2mM DTT, 1mg/ml BSA, 1mM PMSF,
protease inhibitor cocktail [Roche]). Low speed centrifu-
gation of HEK293T cells resulted in a pellet that was used
to isolate intact nuclei as previously described (13).
Cytosolic extracts were obtained from post-mitochondrial
supernatants, and mitochondria were prepared as
described previously (14).
Submitochondrial fractionation
Freshly isolated mitochondria were resuspended in 1ml of
20mM potassium phosphate buffer, pH 7.4, with 150mM
KCl, and sonicated 3 10 s at 70W (Soniprep 150).
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Samples were centrifuged at 100 000g for 1 h at 4C. The
supernatants were retained as the matrix fractions,
whereas pellets comprised mitochondrial membrane
proteins.
Immunoprecipitation
Mitochondria were isolated from PABPC533.HA-,
PABPC533.F-, or PDE12.F-overexpressing HEK293T
cells and treated with proteinase K (PK) (0.02mg/5mg
mitochondria) for 30min on ice. PK was inactivated
with PMSF and then mitochondria were lysed in lysis
buffer (50mM Tris–HCl, [pH 7.4]; 150mM NaCl, 1mM
EDTA, 1% triton X-100). Debris was removed by centri-
fugation at 8000g max, and supernatant was incubated
with EZview Red Anti-HA affinity gel (Sigma) or
anti-FLAG M2 affinity gel (Sigma) for 1 h at 4C. Beads
were washed three times in wash buffer (50mM Tris–HCl,
pH 7.4; 150mM NaCl). In the case of HA immunopre-
cipitation, beads were boiled, centrifuged and supernatant
was used for immunoblotting. In the case of FLAG
co-immunoprecipitation experiments, proteins were
eluted from beads using 3X FLAG peptide (Sigma).
Iodixanol density gradients
Purified mitochondria were treated with 100 mg/ml trypsin
for 30min at room temperature, washed, lysed with 0.4%
dodecyl maltoside (DDM) and loaded on to a 20–42.5%
iodixanol density gradient (Sigma) and ultracentrifuged at
100 000g for 14 h at 4C.
Mitochondrial DNA analysis
Mitochondrial DNA was extracted and analysed via
Southern blotting as previously described (14).
In silico analysis for generating the dATI inventory
Protein sequences from the human and mouse genomes
were downloaded from the ensembl genome browser,
release 61 (15). Human–mouse orthology data were
obtained from the ensembl genome browser via BioMart
(www.ensembl.org/biomart.martview). For all protein se-
quences, each methionine occurring in the first quarter of
the sequence was queried for possible dATI, with mito-
chondrial targeting predicted using Mitoprot (16),
TargetP (17) and iPSORT (18). Genes were considered
mitochondrial when they encoded at least one protein,
which, when encoded from an alternative translation
site, satisfied two of the following three criteria: (i)
Mitoprot score >0.95; (ii) TargetP score >0.95 and (iii)
positive iPSORT result. Retaining only those genes con-
sidered mitochondrial for both their human and mouse
orthologs further filtered the inventory. Finally, the
genes whose protein products were predicted to localize
to mitochondria if their translation would start at M1
were removed from the inventory. Genes whose protein
products that started at M1 were considered mitochon-
drial when they, satisfied two of the following three
criteria: (i) Mitoprot score >0.5; (ii) TargetP score >0.5
and (iii) positive iPSORT result.
RESULTS
A genome-wide screen identifies 126 candidate
dATI-dependent mitochondrial proteins
As a test of the idea that many proteins achieve mitochon-
drial targeting via downstream alternative translation ini-
tiation (dATI), every in-frame AUG codon within the first
quarter of all annotated human and mouse protein-coding
genes of the ensembl database was assessed as a potential
translation initiation site. The choice to restrict the
analysis to the first quarter of the longest annotated
protein isoform was made to reduce the probability of
identifying gene products that were truncated at the
N-terminus to such an extent that functional domains
within the open reading frame (ORF) were lost. Putative
mitochondrial targeting was evaluated based on predic-
tions from Mitoprot (16), TargetP (17) and iPSORT
(18). Two of three conditions were required: a Mitoprot
score >0.95, a TargetP score >0.95 and a positive
iPSORT result. These criteria were established with the
aim of minimizing false positives; however, this risked
failing to identify genuine mitochondrial proteins that
depend on dATI for targeting to the organelle.
When the computational analysis was applied, 886
entries (473 and 413, human and mouse genes, respect-
ively) scored above the threshold set (Figure 1A).
Human and mouse data sets were combined and only
orthologous genes were retained, yielding 168 candidates.
Forty-two of these were excluded (Supplementary Table
S1) because the full-length protein has a plausible N-ter-
minal MTS (an MTS starting at M1), and approximately
half of these are found in the Mitocarta database (19).
This suggests that these proteins can achieve mitochon-
drial targeting without the need for dATI. Thus, the
final catalogue (Supplementary Table S2) comprised 126
genes that potentially depend on dATI to generate a
mitochondrially targeted protein.
Antibody- and immunocytochemistry-based
identification of dATI candidates
Of the 126 genes identified by the in silico screen
(Supplementary Table S2), five are recognized mitochon-
drial proteins in the Mitocarta database (19), and 17
others can be found in the MitoMiner database (20).
Thus, the computational screen identified >100 proteins
that have had no prior evidence of mitochondrial localiza-
tion. This might be taken to imply that the screen
generated many false positives. However it is noteworthy
that the established dATI-dependent mitochondrial
protein, c-Erb A a1, is missing from the Mitocarta and
Mitominer databases. As an initial test of the validity of
the dATI screen, the cellular distribution of 26 proteins
with no prior localization to mitochondria was analysed.
Fifteen proteins predicted by the in silico screen to have a
cryptic MTS, and 11 negative controls, were studied in
enriched nuclear, cytosolic and mitochondrial prepar-
ations, by immunoblotting or by immunocytochemistry.
The proteins were selected without bias, while aiming to
reflect a range of biological processes. For immunoblot-
ting analyses, the prediction, a priori, was that the
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antibody would cross-react with a protein that was (i)
enriched in mitochondrial extracts, (ii) shorter than the
annotated full-length protein, while being maximally of
a size predicted by dATI and (iii) resistant to trypsin deg-
radation prior to mitochondrial lysis, like other internal
mitochondrial proteins. For immunocytochemistry
analysis, two versions of the cDNA were cloned, the
full-length ORF, and a truncated form starting at the
internal AUG predicted to mark the start of the cryptic
MTS. In the immunoblotting experiments, 10 of 15
proteins tested fulfilled the criteria, suggesting they have
a mitochondrial isoform. The 10 positive proteins were
Figure 1. Output of a computational screen for genes encoding dATI-dependent mitochondrial isoforms and identification of eight truncated mito-
chondrial isoforms via immunoblotting. (A) Venn diagram of genome-wide in silico identification of putative genes targeted to mitochondria via dATI.
473 human and 413 mouse genes are predicted to encode a cryptic MTS, of which 168 are conserved between the two species. After filtering out 42 genes
predicted to produce a mitochondrial protein based on translation starting at the first methionine, M1, 126 genes remained (Supplementary Table S2).
(B) Immunoblot analysis of candidate gene products [ARAP1, FBXL12, MTSS1L, LEPRE1, TRIM32, NOX3, CLASP2 and FOXH1 from nuclear
(Nuc), cytosolic (Cytos) and mitochondrial fractions of HEK293T cells]. Mitochondrial fractions were treated with 0, 10, 50 or 100mg/ml trypsin. L,
mitochondria lysed with 1% Triton X-100 and treated with 100mg/ml trypsin. Gray arrowhead, full-length protein; white arrowhead, putative dATI
isoform. Full-length and predicted dATI protein products of candidate genes are schematically depicted to the right of each immunoblot. Domains are as
follows: PH, Pleckstrin homology; ArfGAP, Arf GTPase-activating protein; RhoGAP, Rho GTPase-activating protein; RA, Ras association; FBL,
F-box-like; IMD, IRSp53/MIM homology domain; 2OG-Fell Oxy, 2OG-Fe(II) oxygenase superfamily; Zf-RING LisH: RING-type zinc-finger, LisH
dimerization motif; NHL: NHL repeat; (NCL-1, HT2A and Lin-41); Ferric reduct: Ferric reductase like transmembrane component; FADB:
FAD-binding domain; Fe reduct NADB: Ferric reductase NAD-binding domain; CLASP_N: N-terminal region of CLIP-associated proteins.
TOM20 was used to show efficiency of trypsin treatment. TFAM, CALNEXIN, Splicing factor 2 (SF2) and glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) were used as mitochondrial, endoplasmic reticulum, nuclear and cytosolic markers, respectively.
Nucleic Acids Research, 2013, Vol. 41, No. 4 2357
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ARAP1, FBXL12, MTSS1L, LEPRE1, TRIM32, NOX3,
CLASP2 and FOXH1 (Figure 1B), as well as PABPC5
and PIF1a (see below). In the case of FBXL12, the
MTS may not always be cleaved after import, as the
antibody to this protein detected two bands specific to
the mitochondrial cell fraction (Figure 1B).
There was no putative mitochondrial isoform in the
cases of TNIK, PRPSAP2, MBRL or NRF1
(Supplementary Figure S1A). POP1 was another false
positive, based on immunocytochemistry of the full-length
and putative dATI isoform, as both long and short forms
of the protein were targeted exclusively to nucleoli
(Supplementary Figure S2). None of the negative
controls tested yielded a short, trypsin-resistant, mito-
chondrial isoform based on immunoblotting
(Supplementary Figure S1B). Therefore, our screen
achieved a sensitivity and specificity of 77 and 72% re-
spectively, with an estimated false discovery rate (FDR)
of 33%. These results suggest that 85 of the 126
identified genes will prove to encode dATI-dependent
mitochondrial proteins, and thus are strong candidates
for further validation. Nevertheless, multiple methods
will be required to demonstrate that each predicted
dATI-dependent gene product is a bona fidemitochondrial
protein. On the other hand, a dATI variant that is pre-
dicted to be mitochondrial, but not detected in the organ-
elle at first instance, should not be discounted, as dATI
might be tightly regulated in some cases, and so the mito-
chondrial isoform might only be apparent in specific cell
types, environmental conditions or stages of development.
The predicted polyA-binding protein PABPC5 has a
dATI-dependent mitochondrial isoform
Poly(A) tails are attached to the 30-end of almost all
eukaryotic messenger RNAs, including those in
mitochondria (21,22), and polyA-binding proteins
(PABPs) bind to and modulate polyA tail length, with
implications for mRNA stability and translation (22).
Hence, mitochondria are expected to contain one or
more PABPs, yet none had been identified hitherto.
Therefore, the appearance of PABPC5 in the list of
candidate proteins (Supplementary Table S2) was
of particular interest, as it could be the long sought mito-
chondrial PABP (23).
Initiation from an internal AUG codon of Pabpc5 occurs
in vitro, and human mitochondria contain a truncated
isoform of PABPC5 concordant with dATI
The computational analysis predicted that translation ini-
tiation from methionine 33 of PABPC5 would generate a
mitochondrial isoform of the protein. To test this predic-
tion, Pabpc5 cDNAs were introduced into a coupled tran-
scription/translation (TnT) system. Full-length Pabpc5
cDNA (PABPC51) produced two polypeptides
(Figure 2A; lane 2) corresponding to translation
products initiating at M1 and M33, based on comparisons
with an N-terminally truncated template (PABPC533)
(Figure 2A; lane 1), whereas a full-length mutant form
of the protein, where M33 was replaced by isoleucine
(PABPC5M33I) (Figure 2A; lane 3), yielded a single
polypeptide. Thus, the downstream AUG at position 33
is a functional start site.
An antibody to PABPC5 detected two proteins in the
cytosol of HEK293T cells, the lower of which was also
detected in trypsin-treated mitochondria (Figure 2B).
Sub-mitochondrial fractionation localized the protein to
the matrix compartment of the organelle (Supplementary
Figure S3A), and in vitro synthesized PABPC533 resolved
at the same position as the endogenous mitochondrial
isoform of PABPC5 on SDS-PAGE gels (Figure 2C). In
addition, full-length PABPC5 tagged at the
carboxyl-terminus (PABPC51.HA) was targeted princi-
pally to the cytosol based on immunocytochemistry
(Figure 2D), whereas deletion of the first 32 residues
(PABPC533.HA) resulted in targeting of the protein to
mitochondria, as predicted by the in silico screen
(Figure 2E). Next, mitochondria were purified from trans-
genic HEK293T cells expressing FLAG-tagged PABPC5,
starting at M33 (PABPC533.F), or full-length PABPC5
with a methionine-to-isoleucine mutation at the predicted
internal start site (PABPC5M33I.F). The full-length mutant
protein was readily detectable in whole cell extracts, and
as expected for a cytosolic protein, the little associated
with isolated mitochondria was completely degraded
with the addition of trypsin (Figure 2F). In contrast,
tagged PABPC533 co-purifying with mitochondria
survived trypsin treatment (Figure 2F). Therefore, trans-
lation initiation from methionine 33 of Pabpc5 yields a
protein that is targeted to mitochondria in living cells.
Mitochondrial PABPC5 co-fractionates with mtDNA to a
similar extent as DNA polymerase c and mitochondrial
single-stranded DNA-binding protein
To determine whether PABPC5 in mitochondria
associated with nucleic acid, mitochondrial lysates were
subfractionated through an iodixanol gradient. Southern
blotting was used to detect mtDNA, and the
co-fractionation of PABPC5 and known mtDNA replica-
tion proteins was assessed by immunoblotting. The
majority of the signal from proteins known to be
involved in mtDNA metabolism, such as TWINKLE,
TFAM, SSBP1 and POLG1, resolved in the same frac-
tions as mtDNA, whereas the chaperone protein HSP60
was mainly in the mtDNA-free fractions (Figure 3A).
PABPC5 showed a distribution similar to SSBP1 and
POLG1 (Figure 3A), suggesting that it is associated with
mtDNA or RNA, as mitochondrial ribosomes and
mRNAs co-fractionate with the DNA on iodixanol gradi-
ents (24).
Depletion of mtDNA destabilizes mitochondrial PABPC5
Many proteins associated with mitochondrial nucleic acid
are rapidly turned over in its absence (25). To test whether
mitochondrial PABPC5 was dependent on nucleic acid for
its stability, HEK293T cells were largely depleted of their
mitochondrial DNA and RNA by treatment with
ethidium bromide (26,27). In these conditions, mitochon-
drial PABPC5 was markedly reduced in abundance, as
were several known mtDNA and RNA-binding proteins,
such as SLIRP, LRPPRC, DHX30, PTCD3, POLRMT
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Figure 2. PABPC5 has a mitochondrial isoform consistent with dATI from M33. (A) SDS-PAGE of [35S]-methionine-labelled PABPC5 polypeptide
variants generated in vitro. M33 and M1 denote the methionines where translation starts, while M33I indicates a methionine to isoleucine point
mutation at residue 33 of PABPC5. A consensus Kozak sequence (gccacc) was placed upstream of the first AUG (methionine) codon in each
construct. Schematics of the constructs used as templates are indicated to the right of the representative gel image. ‘X’ in the cDNA schematic
(lane 3) indicates mutation of the methionine residue. (B) Immunoblot analysis of PABPC5 cytosolic (Cytos), and mitochondrial fractions from
HEK293T cells. Mitochondrial fractions were treated with 0, 10 or 50 mg/ml trypsin. Gray arrowhead, full-length protein; white arrowhead, putative
dATI isoform. (C) Immunoblot analysis using anti-PABPC5 to PABPC533 and PABPC5M33I TnT products, total mitochondrial lysate (TM) and a
mitochondrial matrix fraction (Mtrx). Confocal analysis of transiently transfected HOS cells with C-terminal HA-tagged cDNAs encoding
(D) full-length human PABPC5 (PABPC51.HA) or (E) the dATI isoform with the first methionine at residue 33 (PABPC533.HA). Recombinant
proteins were labelled with anti-HA antibody (green), while nuclei (blue) and mitochondria (red) were visualized by staining cells with DAPI and
Mitotracker, respectively. (F) Mitochondria from PABPC5M33I.F- and PABPC533.F-expressing cells (10 ng/ml doxycycline, 24 h) were purified
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and TFAM, whereas the mitochondrial protein Aconitase
II, which does not interact with mtDNA, was unaffected
by this treatment (Figure 3B). These results suggest that
PABPC5 interacts with nucleic acid in mitochondria.
PABPC5 co-immunoprecipitates the mitochondrial
poly(A) polymerase, but not mitochondrial ribosomes
Co-immunoprecipitation experiments, followed by im-
munoblotting, were used to determine potential protein–
protein interactions, using the predicted dATI isoform of
PABPC5, fused to a carboxy-terminal haemagglutinin
(HA) or FLAG tag, as bait. Tagged PABPC533
co-immunoprecipitated the mitochondrial poly(A) poly-
merase (mtPAP), and to a lesser extent LRPPRC,
whereas a FLAG-tagged version of the mitochondrial
deadenylase, PDE12 (28), did not interact with either of
these proteins (Figure 3C and Supplementary Figure
S3B). There was no enrichment of the mitochondrial
RNA-binding protein SLIRP, nor was there any signifi-
cant co-immunoprecipitation of the mitochondrial riboso-
mal protein, MRPS18, or the abundant respiratory chain
subunit cytochrome c oxidase (COXIV) (Figure 3C and
Supplementary Figure S3B). The specific interaction of
PABPC533 with mtPAP and LRPPRC, but not
MRPS18, suggests it associates with mRNAs that are in-
dependent of mitochondrial ribosomes.
The RNA/DNA helicase PIF1a has a dATI-dependent
mitochondrial isoform
Another dATI candidate from the in silico screen was the
RNA/DNA helicase PIF1a. In yeasts, the PIF1 gene
product is essential for mitochondrial DNA maintenance
(29), and the mitochondrial isoforms of budding and
fission yeast PIF1 are known to be generated via ATI,
not dATI. Translation initiation from the first AUG
codon of the ORF yields the mitochondrial isoform,
whereas translation from a downstream in-frame AUG
codon generates yeast nuclear PIF1 (30,31). In contrast,
none of the annotated PIF1 transcripts in a variety of
vertebrates possesses an in-frame AUG that could
append an MTS to the protein (Supplementary Table
S3). Nor do these PIF1 orthologs contain a proximal
upstream ORF (uORF) adjacent to the main coding
sequence (CDS), of the type associated with vertebrate
RNase H1 genes (8), based on the annotated 50 UTR
sequences of all available PIF1 sequences in the NCBI
and ensembl databases (Supplementary Table S3). It has
been suggested that human PIF1a is a nuclear protein
(32,33), and that a mitochondrial form of PIF1 (PIF1b)
is generated via alternatively splicing (33). However, PIF1
was identified in our computational screen as a candidate
dATI protein (Supplementary Table S2), and sequence
alignments of PIF1 of several mammals revealed a poten-
tial MTS that would be revealed by dATI, from human
M54 and mouse M67 (Figure 4A and B).
To screen for the predicted PIF1a product of dATI,
cDNAs were translated in vitro. Full-length Pif1a cDNA
produced two polypeptides (Figure 4C; lane 2), the shorter
of which was not detected when the predicted dATI start
site was modified by substituting methionine 54 with iso-
leucine (PIF1aM54I) (Figure 4C; lane 3), and a PIF1a
cDNA lacking the first 53 codons of the ORF (PIF1a54)
yielded a single polypeptide that was the same size as the
short form of PIF1a1 (Figure 4C; lane 1). These results
indicate that dATI occurs from the AUG encoding M54
of Pif1a, in vitro. Because evidence already existed for
nuclear localization of PIF1a (32,33) and the full length
protein is not detectable in mitochondria, we tested the
ability of PIF1a54 to be imported into isolated rat liver
mitochondria, using PIF1a1 and TFAM as negative and
positive controls, respectively. When the PIF1a transla-
tion products were incubated with isolated mitochondria,
the MTS of the predicted dATI isoform, PIF1a54, was
processed and imported in a membrane
potential-dependent manner (Figure 4D, bottom panel),
whereas there was no detectable mitochondrial import of
full-length PIF1a (PIF1a1) (Figure 4D middle panel).
Although the efficiency of import of PIF1a54 into
isolated mitochondria was lower than that of TFAM,
this is also true of other well-established mitochondrial
proteins, including components of the cytochrome c
oxidase holoenzyme (12). The proposed mature form,
PIF1am, was only seen when PIF1a54 translation
products were incubated with mitochondria, and it alone
was resistant to trypsin (Figure 4D, lanes 2 and 3, bottom
panel), strongly suggesting import and processing of
PIF1a54 by mitochondria. The size of PIF1am corresponds
to an endogenous protein detected by a PIF1 antibody
(Figure 3A) whose expression was reduced by a siRNA
targeting PIF1 (Figure 4E) (34).
The predicted dATI forms of human and mouse PIF1
are targeted to mitochondria in cultured cells, and
mutation of an internal AUG codon ablates
mitochondrial localization of PIF1a
PIF1a was shown to display nuclear localization based on
an N-terminal FLAG-tagged (FLAG.PIF1a) form of the
protein (32,33). However, dATI bypasses N-terminal tags;
therefore, cDNAs specifying full-length Pif1a tagged with
HA, either at the N-terminus (HA.PIF1a1) or the
C-terminus (PIF1a1.HA), were transiently expressed in
Figure 2. Continued
and subjected to trypsin protection assays, followed by immunoblotting. Schematic representations of the transgenes are depicted above the
immunoblots. M1, indicates translation initiation at the annotated start methionine of PABPC5 according to ensembl genome browser, release
61; M33, indicates the band corresponding to the cDNA product starting from the dATI residue of PABPC5. Whole cell extract (WCE, lanes 1 and
7); black slope, indicates increasing trypsin concentrations (mg/ml) of 0 (lanes 2 and 8); 10 (lanes 3 and 9); 50 (lanes 4 and 10); and 100mg/ml (lanes 5
and 11). L, mitochondria lysed with 1% Triton X-100 and treated with 100 mg/ml trypsin, lanes 6 and 12. PABPC5.F transgenes were detected with
anti-FLAG antibody. Heat shock protein 60 (HSP60), mitochondrial marker; GAPDH, cytosolic marker. TOM20 was used to show efficiency
of trypsin treatment. Full-length and predicted dATI protein products of candidate genes are schematically depicted to the right. RRM1, RNA
recognition motif.
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human cells. HA.PIF1a1, like FLAG.PIF1a, was located
exclusively in the nucleus (Figure 5A), whereas the
products of the C-terminally tagged, full-length PIF1a
cDNA (PIF1a1.HA) co-localized chiefly with
mitochondria, with a small amount of signal detected in
nuclei (Figure 5B). Enforced translation from M54
(PIF1a54.HA) resulted in exclusive mitochondrial target-
ing of the protein (Figure 5C), whereas replacing M54
with isoleucine (I54) yielded a protein that did not
co-localize with mitochondria (Figure 5D). These results
show that a functional MTS is revealed when human
PIF1a starts at M54, and that this residue is required to
generate a mitochondrial isoform of PIF1a. Analysis of
mouse PIF1 constructs provided further support for the
generation of a mitochondrial-targeted form of PIF1 via
dATI, as mPIF167.HA (the mouse equivalent of
PIF1a54.HA) co-localized with mitochondria (Figure
5E), whereas there was no detectable PIF1 in
mitochondria after mutating the AUG codon predicted
to yield translation initiation of the mitochondrial
isoform of mouse PIF1 (mPIF1M67I.HA) (Figure 5F).
N-terminally truncated human PIF1a is imported and
processed by mitochondria in cultured cells
Subcellular fractions were prepared from human cells ex-
pressing PIF1a1.HA, PIF1a54.HA or PIF1aM54I.HA to
determine the location of the recombinant proteins.
Tagged full-length PIF1a (M1) was the only signal
detected in purified nuclei (Figure 6A, lane 1), and
although some of this isoform was also associated with
mitochondrial fractions (Figure 6A, lane 2), it was
degraded by trypsin treatment (Figure 6B, lanes 3–5).
The mitochondrial extracts additionally contained two
shorter PIF1a products, one corresponding to the
pre-protein (M54) and the other to a shorter protein (m)
(Figure 6A, lane 2). We infer that the shorter of the two is
the mature form of mitochondrial PIF1a, both because it
is the more abundant and it is similar in size (the small
difference being attributable to the tag) to an endogenous
mitochondrial protein identified by the PIF1 antibody
(Figures 3A and 4E). Consistent with this interpretation,
cells expressing PIF1a54.HA produced only the two
presumed mitochondrial-specific species, M54 and m,
both of which were resistant to degradation by trypsin
(Figure 6C). Thus, full-length PIF1a is outside
mitochondria, whereas M54 and m are located inside the
organelle. Both these mitochondrial isoforms depend on
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Figure 3. PABPC5 co-precipitates mitochondrial RNA-binding
proteins and is dependent on mitochondrial nucleic acids for its stabil-
ity. (A) Mitochondria were isolated from HEK293T cells,
trypsin-treated (50mg/ml), lysed and centrifuged through an iodixanol
Figure 3. Continued
gradient. Fractions were collected from the bottom of the tube and
then subjected either to DNA extraction, followed by Southern
blotting, or to SDS-PAGE, followed by immunoblotting. Numbers
above the immunoblots indicate iodixanol fractions, in order of collec-
tion. (B) After HEK293T cells were either grown under normal condi-
tions (Con) or treated with ethidium bromide (100 ng/ml) for 72 h
(Dep), mitochondrial lysates were fractionated and analysed as per
panel A. (C) Mitochondria were isolated from cells overexpressing
PABPC533.HA after 72 h of doxycycline (30 ng/ml) treatment,
followed by immunoprecipitation with anti-HA agarose beads.
Immunoblotting was used to determine the extent of
co-immunoprecipitation of selected proteins using 2.5% of input,
flow-through (FT) and wash, and 5% of the eluate.
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Human           -------------MLSGIEAAAGEYEDSELRCRVAVEELSPGGQPRRRQALRTAELSLGR 47
Orangutan       -------------MLSGIEAAAGEYEDSELRCRVAVEELSPGGQPRRRQALRTAELSLGR 47
Mouse           MRSGLCTPAEALEMPSSTEAATDECDDAELRCRVAVEELSPGGQPRKRQALRAAELSLGR 60
Pig             -------------MLSGTQAAAAESEDAELRCRVAVEELSPGGQPRRRQALRTAELSLGR 47
M1
PIF1
M1A
Cow             -LRSFCRPAEAAAMLSGTQAAAAECEDGELRCRVAVEELSPGGQPRRRQSLRTAELSLGR 59
Dolphin         -------------MLSGTQAVAAECADAELRCRVAVEELSPGGQPRRRQALRTAELRLGR 47
Megabat -------------TLSGTPAEAVECEDAELRCRVAVEELSPGGQPRRRQALRTAELSLGR 47
*.  * : *  *.******************:**:**:*** ***
Human           NERRELMLRLQAPGPAGRPRCFPLRAARLFTRFAEAGRSTLRLPAHDTPGAGAVQLLLSD 107
Orangutan       NERRELMLRLQAPGPAGRPRCFPLRAARLFTRFAEAGRSTLRLPAHGAPGAGAVQLLLSD 107
Q G G C G S G G GS Q S 120
M54
(human)
M67
(mouse)
Mouse           NERRELMLRL AP PT RPR FPLRAVRLFTRFAAT R TLRLPTD VP A V LLL D 
Pig             NERRELMLRLKAPGPAGRPRCFPLRAARLFTRFAAMGRSTLRLPAYGASPAGAVQLLLSD 107
Cow             NERRELMLRLQAPGPAGRPRCFPVRAARLFTRFAAAGRSTLRFPADSTPRASAVQLLLSD 119
Dolphin         NERRELMLSLQAPGPAGRPRCFPLRAARLFTRFAASGRSTLRLPADGAPRTGAVQLLLSD 107
Megabat NERRELMLRLQAPGPAGRPRCYPLRAARLFTRFAATGRSTLRLPAEGAPRTGAVQLLLSD 107
******** *:****:*****:*:**.*******  ******:*: ... :.:*******
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Figure 4. Mammalian PIF1 has a predicted dATI-dependent mitochondrial isoform, some of which can be imported into isolated mitochondria.
(A) N-terminal amino acid sequence alignment of PIF1 between human, orangutan, mouse, pig, cow, dolphin and megabat. M1 and M54 above the
alignment correspond to methionines 1 and 54, respectively of human PIF1a. Green font and box, canonical start sites in mouse and human; red font
and box, putative methionine residue where dATI begins; blue font, Mitoprot-predicted cleavable MTS. (B) In silico mitochondrial targeting
prediction scores from: Mitoprot, TargetP, Predotar (35), PSORTII (36) and iPSORT of human and mouse PIF1. ‘M’ followed by a number, on
the left side of the heat map, indicate the methionine residue numbers; red-coloured boxes in the heat map indicate strong prediction for
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Figure 4. Continued
mitochondrial targeting. (C) SDS-PAGE of [35S]-methionine-labelled human PIF1a polypeptide variants generated in vitro. M54 and M1 refer to the
methionines where translation starts, while M54I indicates a methionine to isoleucine point mutation at residue 54 of PIF1a. A consensus Kozak
sequence (gccacc) was placed upstream of the first AUG (methionine) codon in each construct. Schematics of the constructs used as templates are
indicated to the right of the representative gel image. ‘X’ in the cDNA schematic (lane 3) indicates mutation of the methionine residue.
(D) [35S]-methionine-labelled TFAM (positive control), PIF1a1 and PIF1a54 were incubated with isolated rat liver mitochondria. 1 mM FCCP
(lanes 5–7) was used to dissipate membrane potential. White arrowheads indicate imported polypeptide. Import efficiency was determined relative
to import of TFAM. Start methionines are indicated to the right of the gel images. (E) HEK293T cells were transfected with 200 pmol of scrambled
siRNA (siCON) or siRNA targeted towards PIF1 (siPIF1). Forty-eight hours later, whole cell extracts were used for immunoblotting with anti-PIF1.
GAPDH was used as a loading control. The chart accompanying the immunoblots shows the extent of knockdown relative to GAPDH protein
(n=3 independent experiments).
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Figure 5. Immunocytochemistry of ectopically expressed human and mouse PIF1 suggests mitochondrial targeting via dATI. HOS cells were
transiently transfected with human Pif1a full-length cDNA containing a HA tag on either the (A) N-terminus (HA.PIF1a1) or (B) C-terminus
(PIF1a1.HA). The remaining Pif1a constructs were HA-tagged on the C-terminus, consisting of Pif1a.HA cDNAs that were (C) forced to start at
M54 (PIF1a54.HA) or (D) with a methionine to isoleucine substitution at residue 54 (PIF1aM54I.HA). Mouse PIF1 (mPIF1) constructs were
C-terminally tagged and included (E) a cDNA forced to start translation at M67 (mPIF167.HA) or (F) a cDNA encoding a methionine-to-isoleucine
mutation at residue 67 (mPIF1M67I.HA). Recombinant proteins were labelled with anti-HA antibody (green), nuclei were stained blue with DAPI,
and mitochondria were stained red with Mitotracker.
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initiation at M54, as neither was detected in cells express-
ing the PIF1aM54I.HA variant, and all derivatives of
PIF1aM54I.HA were degraded when mitochondria were
exposed to trypsin (Figure 6D).
A species (cPIF1a) migrating between M54 and m was
detected in cells expressing PIF1a1.HA (Figure 6B, lane
1), and this was the major product in PIF1aM54I.HA cells
(Figure 6D, lanes 1 and 2). In the latter cells, the recom-
binant protein was dispersed throughout the cytosol
(Figure 5D), and cPIF1a did not survive trypsin treatment
of intact mitochondria (Figure 6B and D). Thus, cPIF1a
probably represents a proteolytic cleavage product that is
formed after export of tagged PIF1a from the nucleus, as
occurs to the native protein during the course of the cell
cycle (32). In contrast, murine PIF1M67I.HA was
concentrated in the nucleus (Figure 5F), and so it may
not be recognized by the human nuclear export machin-
ery. Similarly, the HA N-terminal tag may interfere with
nuclear export of PIF1a1 (Figure 5A). In summary, dATI
from the AUG corresponding to M54 of human Pif1a
generates a pre-protein, PIF1a54, which is cleaved after
mitochondrial import, yielding a mature mitochondrial
isoform, PIF1am, and mutation of the predicted dATI
sites ablates mitochondrial isoforms of human and
mouse PIF1.
Endogenous N-terminally truncated PIF1a is present in
mitochondria and co-fractionates with mtDNA
The mitochondrial lysates fractionated by iodixanol
gradient sedimentation and probed for PABPC5 were
also used to evaluate endogenous forms of PIF1. The
most abundant form of PIF1 detected by immunoblotting
corresponded to PIF1am (the presumed mature dATI
isoform of PIF1a), 30% of which co-fractionated with
mtDNA (Figure 3A). The largest species detected by the
PIF1 antibody was a polypeptide of 75 kDa, which is the
predicted size of PIF1b (33), and it was concentrated in
the same fractions as the mtDNA. Thus, there appear to
be two forms of PIF1 in human mitochondria, PIF1am
and PIF1b, both of which may interact with mtDNA.
DISCUSSION
The mammalian mitochondrial proteome is estimated at
1500 proteins. If accurate, then some 400 mitochondrial
proteins remain to be identified (19). The dATI-generated
mitochondrial proteins predicted from our analysis could
account for a substantial fraction of the ‘missing’ mito-
chondrial proteome, as >100 gene products in our list
have not previously been annotated as mitochondrial
proteins. Ten of 15 candidates tested from the 126-gene
inventory appear to have a form of the protein in
mitochondria corresponding to the predicted dATI
isoform. Taking account of the estimated false discovery
rate of 33%, then 85 of the identified genes may prove to
yield proteins targeted to mitochondria in a
dATI-dependent manner. However, in view of the low
specificities of mitochondrial prediction programs, it is in-
evitable that many genes will be missing from the inven-
tory. The thyroid hormone receptor c-Erb A a1 (11) is a
known example. Thus, the number of proteins targeted to
mitochondria via dATI could be in the hundreds.
Although the dATI screen could be refined further to
include the likes of c-Erb A a1, simply lowering the thresh-
old for acceptance will inevitably produce a marked
increase in false positives. This might be offset in other
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Figure 6. Subcellular fractionation confirms mitochondrial targeting and processing of the dATI forms of PIF1a54 in cells. (A) Purified nuclei (Nuc)
and mitochondria (Mt) were isolated from HEK293T cells stably expressing PIF1a1.HA followed by immunoblot analyses. Mitochondria from
transgenic HEK293T cells expressing (B) PIF1a1.HA, (C) PIF1a54.HA, or (D) PIF1aM54I.HA were purified and subjected to trypsin protection
assays, followed by immunoblotting. Whole cell extracts (WCE) were fractionated alongside mitochondrial lysates to show all products of the
cDNAs. Transgenes were expressed by the addition of 10 ng/ml doxycycline for 24 h. Schematic representations of the transgenes are depicted below
the immunoblots. M1, indicates translation initiation at the annotated start methionine of PIF1a according to ensembl genome browser, release 61;
M54, the band corresponding to the dATI residue of PIF1a; m, the putative mature product of PIF1a.HA after mitochondrial import and removal
of the MTS. (B–D) WCE (lane 1); black slope, indicates increasing trypsin concentrations of 0, 10, 50 and 100mg/ml (lanes 2–5, respectively). L,
mitochondria lysed with 1% Triton X-100 and treated with 100mg/ml trypsin (lane 6). PIF1a.HA transgenes were detected with anti-HA antibody.
TFAM and SF2 are mitochondrial and nuclear markers, respectively. TOM20 was used to show efficiency of trypsin treatment. (B and D)
cPIF1a.HA, processed full-length PIF1a that resides in the cytoplasm, not in mitochondria.
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ways, such as a greater demand for conservation among
diverse species, or the incorporation of additional algo-
rithms that predict mitochondrial targeting (37).
Conservation is a critical filter because randomly
generated peptides can create an MTS (38). As noted
above, evidence of mitochondrial involvement will be an
important guide in many cases and this is likely to be
facilitated by the explosion in RNA expression data
providing comprehensive details of co-expression in a
variety of cell and tissue types. Detailed mining of
existing and new mitochondrial proteome studies will
also doubtless reap reward, as it is likely that many mito-
chondrial proteins have been mistakenly dismissed as con-
taminants, b-actin being a case in point (14). Conversely,
it is possible that some genes on the list have genuine
mitochondrial isoforms that do not depend on a canonical
N-terminal MTS, or are generated via alternative tran-
scripts, rather than by dATI. Ultimately any in silico
prediction of putative internal start codons will require
experimental verification by multiple methods for each
and every candidate, as per PIF1 and PABPC5.
Although the known or inferred functions of the 126
candidate mitochondrial dATI proteins are highly
varied, they can be grouped into a number of categories
(Table 1). Thirty-one of the candidates have links to RNA
or DNA metabolism, and these can be further sub-divided
into transcriptional regulation, post-transcriptional modi-
fication and DNA replication or repair. The earlier iden-
tification of nuclear transcription factors in mitochondria
led others to suggest that the regulation of mitochondrial
gene expression might share certain aspects with nuclear
gene expression (39), and 17 candidate dATI-generated
mitochondrial proteins are recognized transcriptional
regulators (Table 1). Actomyosin has recently been
found inside mammalian mitochondria and implicated in
mtDNA maintenance (14), and 12 candidates have links
to actin binding and organization, two of which were
substantiated by immunoblotting (Figure 1B).
Furthermore, the list includes two members of the WNK
(WNK lysine-deficient protein kinase) serine/threonine
kinase subfamily (WNK1 and WNK2), which act on
Rho GTPases and control actin dynamics. These two
proteins physically interact with one another (40), and
WNK1 enhances the activity of the annotated mitochon-
drial protein, SGK1 (serum- and glucocorticoid-induced
kinase 1) (41). Thus, dATI may be a mechanism of protein
trafficking that maintains the balance between mitochon-
drial and cytoplasmic actin.
dATI-dependent mitochondrial isoforms confound con-
ventional genetic analysis, as gene knockdown and
ablation will affect all the protein isoforms, and so the
relative contributions of the mitochondrial and
non-mitochondrial proteins cannot be judged. Gene re-
placement of one particular isoform could circumvent
this problem, as was achieved for the alternatively
translated DNA ligase III, which identified the mitochon-
drial, not the nuclear, enzyme as the essential variant for
cell viability (42).
Based on the immunoblotting results and the domain
structure of some of the dATI candidates (Figure 1B), loss
of a portion of the N-terminus will affect their function. For
instance, the dATI isoform of FBXL12 is predicted to lack
the F-box-like domain that gives it its name (Figure 1B), and
half of a RNA recognition motif is missing from the mito-
chondrial isoform of PABPC5 (Figure 2F).
The dATI-mediated mitochondrial isoform of PABPC5
Although several mitochondrial proteins have been shown
previously to bind RNA and poly(A) sequences in
mitochondria (43–45), none binds poly(A) tails preferen-
tially. Of the four human PABPC genes, three (PABPC1,
PABPC3 and PABPC4) are established polyA-binding
proteins (46–48); however, none has a predicted
N-terminal MTS based on the annotated first AUG
codon, or downstream AUG codon, and only PABPC5
predicts a dATI-dependent mitochondrial isoform.
Several lines of evidence provide support for the
proposed dATI-mediated mitochondrial isoform of
PABPC5. A cDNA of the complete ORF yields two
proteins, one of which is of the size predicted by dATI,
and when expressed in cells the shorter form is imported
into mitochondria. Endogenous PABPC5 is present in
mitochondria (PABPC5m) based on immunoblotting,
and it co-fractionates with mitochondrial nucleic acids.
PABPC5m is unstable when mitochondrial DNA and
RNA are depleted, and it interacts with mitochondrial
RNA-binding proteins, implying PABPC5 in
mitochondria is bound to RNA. Hence, PABPC5m is
proposed to play a role in post-transcriptional mitochon-
drial RNA metabolism, and based on its high homology
to other PABP family members, it is a highly credible
candidate for the long sought mitochondrial poly(A)-
binding protein. All four PABPCs contain four
non-identical RNA recognition motifs (RRMs).
Typically, these motifs are linked to a C-terminal
domain through a proline-rich (P-rich) region (22).
However, the C-terminus of PABPC1 can be deleted
without affecting poly(A) binding in vitro (49), or
compromising translation in Xenopus (50) or viability in
yeast (51). Only RRM motifs 1 and 2 need be retained to
preserve the protein’s ability to bind to poly(A) tails (52).
Moreover, whereas RRMs 1 and 2 are highly selective for
polyadenylated RNA, RRMs 3 and 4 are less discrimina-
tive, and can also bind AU-rich RNA (48), and this may
be an important feature of the mitochondrial variant of
PABPC5, as some mitochondrial transcripts have been
shown to be polyuridinylated, poly(U) (53,54).
Therefore, although full-length PABPC5 lacks the P-rich
linker region and the C-terminal domain of the other
PABPCs (55), and the dATI form lacks RRM1
(Figure 2F), both cytosolic and mitochondrial isoforms
of PABPC5 are still likely to have the capacity to bind
to polyadenylated RNA. Nevertheless, the structural dif-
ferences between PABPC5 and the other family members
might be indicative of a distinct property or role, and the
function of the shorter mitochondrial isoform may differ
from its cytosolic counterpart.
The dATI mediated mitochondrial isoform of PIF1a
In the case of PIF1a, dATI exposes the MTS and simul-
taneously removes the nuclear localization signal (NLS).
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Prior research on PIF1a assigned it a nuclear location,
based chiefly on N-terminal tagging of the recombinant
protein (32,33). However, N-terminal tags mask mito-
chondrial targeting signals that are present at the
N-terminus (24), and a protein derived from an internal
MTS will be undetectable because dATI bypasses
N-terminal tags. Therefore, the previous approach was
not capable of revealing a mitochondrial isoform of
PIF1a. Accordingly, C-terminal tags are most appropriate
for localization studies of potential mitochondrial
proteins.
Based on its mobility on denaturing gels, the mass of the
dATI-dependent mitochondrial PIF1a (PIF1am) is
estimated at 55±2.5 kDa, placing the cleavage site at
residue 165±30. Despite PIF1a54 being processed to an
even shorter form upon mitochondrial import, to generate
PIF1am, the mature form is not expected to differ substan-
tially from the full-length protein in terms of its core
activities, because the first defined functional SFI
helicase motif begins at residue 224 (56), which PIF1am
appears to retain. Furthermore, a recombinant form of
human PIF1a (PIF1N) lacking the first 166 residues
Table 1. Functional categories of candidate dATI genes
Proposed function of dATI-dependent proteins
Transcriptional
regulation
Post-transcriptional
modification
DNA
Replication/Repair
Actin
cytoskeleton
Kinases Translation
ASH2L C19orf6 C9orf102 ANK2 MINK1 RPL4
C11orf30 DHX15 TEP1 ANK3 MAP4K4 FTSJ3
PHTF1 ERI3 PIF1 ARAP1 MLKL DUS4L
SMARCB1 PABPC5 ZNF335 FARP2 PRKCE EIF2S1
TRRAP POP1 ZRANB3 IQSEC1 TNIK RPS15
ZMYM3 RBM25 IQSEC2 WNK1 BMS1
ZMYM4 SRRM2 MTSS1 WNK2
ELK4 NFKBIL1 MTSS1L WNK4
FOXH1 YTHDC2 MYO10 TBRG4
GATA4 MYO15A CDK12
MLF1 STARD13 DAPK1
NR1I2 ARHGAP32 DGKD
NRF1 DSTYK
PAX4
MYST3
NR6A1
SRFBP1
Collagen Microtubules Beta oxidation Receptors GTP binding Calcium sensing
COL16A1 CLASP2 CPT1B CHRM1 C9orf86 MCTP1
COL27A1 SFI1 CPT1C CHRM5 RASAL3 IQCF5
LEPRE1 ASPM DECR2 GPR162
Channels Trafficking Ubiquitination Cell–cell communication Proteases Transporters
ACCN1 NUP155 FBXL12 DSP MMP25 CNNM2
SCN11A YIPF3 RNF111 DTX4 MMP28 ABCC6
TRPM2 DOPEY1 TRIM32 ICA1 PSMD1 ABCC4
CACNA1B CLINT1 ZYG11B PKP4 RHBDL3
CACNA1F CCDC157 FBXO38 SRCIN1 TMPRSS11F
HCN1 COMMD10 C1QTNF3 CTSF
TMC6 AGBL1
CYBB USP49
Apoptosis Phospho-lipase TCA cycle ROS Nucleotide synthesis
SPATA17 PNPLA6 IDH1 NOX3 PRPSAP2
NOX4
Cysteine modification Retinoic acid metabolism Phospholipid biosynthesis Unknown function
HHAT CYP26A1 PISD FAM160B1
PLCB4 C14orf118
All 126 genes from Supplementary Table S2 were grouped according to known function.
Bold font, genes tested in this study, that have a product in mitochondria based on experiment, unless coloured gray; blue font, genes found in
human Mitocarta; red font, genes found in Mitominer.
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has the same ATPase and helicase activities as the
full-length protein (57). Therefore, the activities of
PIF1am are expected to be similar to its full-length
nuclear counterpart, although contextual differences
between nuclei and mitochondria might mean that the
function of PIF1am is distinct from the long form of
PIF1a, in vivo.
Human PIF1b—the alternatively spliced
mitochondrial isoform
The detection, with an antibody to PIF1, of a protein of a
mass of 75 kDa co-fractionating with mtDNA
(Figure 3A), lends support to the proposal that alternative
splicing gives rise to a dedicated transcript encoding a
human mitochondrial PIF1 isoform, PIF1b (33). PIF1b
is annotated as a manually verified transcript in the
ensembl database. Assuming it is correctly assigned,
PIF1b starts at M1 and so depends on signals located at
the C-terminus (which PIF1a lacks) to achieve mitochon-
drial targeting (33). However, a genetic approach that
targets PIF1b, while sparing PIF1a will be needed to
clarify its physiological importance, as PIF1b does not
appear to be conserved even among primates
(Supplementary Figure S4). Orangutan lacks the consen-
sus splice acceptor site, which in humans gives rise to Pif1b
mRNA, and in mouse there are no annotated alternative
mouse PIF1 isoforms. Although there is a putative AG
splice acceptor site in the mouse Pif1 gene, the resultant
four-nucleotide insertion directly downstream would
create a variant PIF1 unlike human PIF1b
(Supplementary Figure S4). Moreover, this hypothetical
mouse PIF1 mRNA does not contain any appreciable
homology (at the nucleotide level) to the portion of the
human PIF1b protein that is required for mitochondrial
targeting (33). Therefore, there is no evidence of a PIF1b
mouse variant. Nevertheless, there is considerable
sequence variation among mitochondrial targeting
signals and so it remains possible that the mouse PIF1
sequence contains a carboxy-terminal MTS.
The extent of dATI-dependent mitochondrial targeting
An increasing number of nuclear DNA transacting
proteins are also found in mitochondria (33,58–60), but
the task of defining the organelle-specific forms is far from
complete. Information regarding the subcellular localiza-
tion of these proteins is essential for determining their
precise roles within the cell. The identification of
dATI-dependent mitochondrial isoforms of PABPC5
and PIF1a suggests that this trafficking mechanism will
prove to be a significant contributor to the dual targeting
of proteins. Other candidates well worthy of further inves-
tigation for a role in mitochondrial nucleic acid metabol-
ism include the putative RNA exonuclease ERI3 and the
RNA helicase YTHDC2 (Table 1 and Supplementary
Table S2).
The in silico screen and cell biology data of this report
strongly support the idea of dATI playing an important
role in targeting proteins to mitochondria, potentially
accounting for up to half of the unassigned mitochondrial
proteins, or 10% of the total mitochondrial proteome.
This raises the question of how expression of this class of
genes is regulated and the nature of the mitochondrial–
nuclear and mitochondrial–cytoplasmic communication
pathways involved. The use of dATI permits antagonistic
regulation, as translation of one isoform inherently
opposes translation of the other isoform (61); therefore,
deregulated ATI could result in category of human
disease.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–3 and Supplementary Figures
1–4.
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